Literature DB >> 29770019

Measles surveillance in Canada: 2015.

L Sherrard1, J Hiebert2, J Cunliffe1, L Mendoza2, J Cutler1.   

Abstract

BACKGROUND: Measles has been eliminated in Canada since 1998. Every year, the Public Health Agency of Canada presents epidemiologic evidence to the Pan American Health Organization (PAHO) to verify that measles elimination continues in Canada.
OBJECTIVE: To describe measles activity in Canada for 2015 as updated evidence for continued measles elimination status.
METHODS: Measles surveillance data were captured by the Canadian Measles and Rubella Surveillance System (CMRSS) and the Measles and Rubella Surveillance (MARS) pilot project and assessed for distribution by demographics and risk factors. Outbreak characteristics were summarized and genotypic and phylogenetic analyses were conducted and described. Surveillance data for 2015 were evaluated against PAHO's essential criteria for measles elimination status.
RESULTS: In 2015, the incidence of measles in Canada was 5.5 cases per 1,000,000 population, with 196 cases across four provinces. The majority of cases (87.2%, n=171) were not immunized and both age-specific incidence rates and case counts were highest among those aged 10 to 14 years (29.5 cases per 1,000,000 population, n=55). This was due in large part to a sizeable outbreak in a non-immunizing religious community. Overall, 10.7% (n=21) of cases were hospitalized. Genotype information was available for 100% of measles events (4/4 outbreaks and 6/6 sporadic cases). Canada met or partially met most of PAHO's criteria for verification of measles elimination.
CONCLUSION: Although importations and areas of low immunization coverage continue to challenge Canada's elimination status, surveillance data for 2015 provides strong evidence that measles elimination has been maintained.

Entities:  

Year:  2016        PMID: 29770019      PMCID: PMC5757721          DOI: 10.14745/ccdr.v42i07a01

Source DB:  PubMed          Journal:  Can Commun Dis Rep        ISSN: 1188-4169


  13 in total

1.  Monitoring progress towards measles elimination.

Authors: 
Journal:  Wkly Epidemiol Rec       Date:  2010-12-03

2.  Guidelines for the documentation and verification of measles, rubella, and congenital rubella syndrome elimination in the region of the Americas.

Authors:  Carlos Castillo-Solórzano; Susan E Reef; Ana Morice; Jon Kim Andrus; Cuauthémoc Ruiz Matus; Gina Tambini; Socorro Gross-Galiano
Journal:  J Infect Dis       Date:  2011-09-01       Impact factor: 5.226

3.  Genetic diversity of wild-type measles viruses and the global measles nucleotide surveillance database (MeaNS).

Authors: 
Journal:  Wkly Epidemiol Rec       Date:  2015-07-24

4.  MEGA5: molecular evolutionary genetics analysis using maximum likelihood, evolutionary distance, and maximum parsimony methods.

Authors:  Koichiro Tamura; Daniel Peterson; Nicholas Peterson; Glen Stecher; Masatoshi Nei; Sudhir Kumar
Journal:  Mol Biol Evol       Date:  2011-05-04       Impact factor: 16.240

5.  Global distribution of measles genotypes and measles molecular epidemiology.

Authors:  Paul A Rota; Kevin Brown; Annette Mankertz; Sabine Santibanez; Sergey Shulga; Claude P Muller; Judith M Hübschen; Marilda Siqueira; Jennifer Beirnes; Hinda Ahmed; Henda Triki; Suleiman Al-Busaidy; Annick Dosseh; Charles Byabamazima; Sheilagh Smit; Chantal Akoua-Koffi; Josephine Bwogi; Henry Bukenya; Niteen Wairagkar; Nalini Ramamurty; Patcha Incomserb; Sirima Pattamadilok; Youngmee Jee; Wilina Lim; Wenbo Xu; Katsuhiro Komase; Makoto Takeda; Thomas Tran; Carlos Castillo-Solorzano; Paul Chenoweth; David Brown; Mick N Mulders; William J Bellini; David Featherstone
Journal:  J Infect Dis       Date:  2011-07       Impact factor: 5.226

6.  Exploring gaps in surveillance of a small measles outbreak in Toronto, Canada.

Authors:  E Gournis; A Shane; E Shane; A Arthur; L Berger
Journal:  Can Commun Dis Rep       Date:  2016-07-07

Review 7.  Consensus conference on measles.

Authors: 
Journal:  Can Commun Dis Rep       Date:  1993-05-30

8.  Measles surveillance in Canada: Trends for 2014.

Authors:  L Sherrard; J Hiebert; S Squires
Journal:  Can Commun Dis Rep       Date:  2015-07-02

9.  Measles surveillance in Canada: Trends for 2013.

Authors:  A Shane; J Hiebert; L Sherrard; H Deehan
Journal:  Can Commun Dis Rep       Date:  2014-06-12

10.  Measles outbreak--California, December 2014-February 2015.

Authors:  Jennifer Zipprich; Kathleen Winter; Jill Hacker; Dongxiang Xia; James Watt; Kathleen Harriman
Journal:  MMWR Morb Mortal Wkly Rep       Date:  2015-02-20       Impact factor: 17.586

View more
  5 in total

1.  Vaccine-associated measles in a healthy 40-year-old woman.

Authors:  Lucas Churchill; Francesco A Rizzuti; Kevin Fonseca; Joseph Kim
Journal:  CMAJ       Date:  2018-09-04       Impact factor: 8.262

2.  Parental Hesitancy About Routine Childhood and Influenza Vaccinations: A National Survey.

Authors:  Allison Kempe; Alison W Saville; Christina Albertin; Gregory Zimet; Abigail Breck; Laura Helmkamp; Sitaram Vangala; L Miriam Dickinson; Cindy Rand; Sharon Humiston; Peter G Szilagyi
Journal:  Pediatrics       Date:  2020-06-15       Impact factor: 7.124

Review 3.  Revisiting the 2014-15 Disneyland measles outbreak and its influence on pediatric vaccinations.

Authors:  Margaret K Doll; John W Correira
Journal:  Hum Vaccin Immunother       Date:  2021-09-08       Impact factor: 4.526

4.  User-Driven Comments on a Facebook Advertisement Recruiting Canadian Parents in a Study on Immunization: Content Analysis.

Authors:  Jordan Lee Tustin; Natasha Sarah Crowcroft; Dionne Gesink; Ian Johnson; Jennifer Keelan; Barbara Lachapelle
Journal:  JMIR Public Health Surveill       Date:  2018-09-20

5.  Measles Outbreak in Unvaccinated and Partially Vaccinated Children and Adults in the United States and Canada (2018-2019): A Narrative Review of Cases.

Authors:  Adekunle Sanyaolu; Chuku Okorie; Aleksandra Marinkovic; Oladapo Ayodele; Abu Fahad Abbasi; Stephanie Prakash; Jessica Gosse; Sadaf Younis; Jasmine Mangat; Henry Chan
Journal:  Inquiry       Date:  2019 Jan-Dec       Impact factor: 1.730

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.